Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Dig Surg. 2010;27(1):56-60. doi: 10.1159/000268427. Epub 2010 Apr 1.
Hepatocellular adenoma (HA) is an increasingly prevalent benign liver tumor that is strongly associated with use of oral contraceptive medication. The diagnosis is often made after abdominal imaging in female patients with sudden abdominal pain, with or without signs of hemorrhage. Especially larger adenomas are of potential hazard to patients, because of the increased likelihood of rupture or malignant degeneration. Standard treatment of larger adenomas has since long consisted in surgical resection, both for non-ruptured and for ruptured tumors. Although resection is still considered the gold standard, recent reports have advocated initial conservative management. Recently, newer and less invasive methods using selective transarterial embolization have been described that can successfully stop bleeding and even lead to tumor regression. This review addresses different treatment options and recent advances regarding this relatively new condition, focusing mainly on treatment of bleeding and ruptured tumors in an acute setting. A possible algorithm for optimal treatment is presented.
肝细胞腺瘤(HA)是一种越来越常见的良性肝肿瘤,与口服避孕药的使用密切相关。女性患者常因突然腹痛(伴或不伴出血症状)而行腹部影像学检查而做出诊断。特别是较大的腺瘤对患者存在潜在危害,因为其破裂或恶性转化的可能性增加。对于较大的腺瘤,标准治疗一直是手术切除,无论是未破裂的还是破裂的肿瘤。尽管切除术仍被认为是金标准,但最近的报告提倡初始保守治疗。最近,使用选择性经动脉栓塞的较新的、创伤较小的方法已被描述,这些方法可以成功止血,甚至导致肿瘤消退。本综述主要针对急性情况下出血和破裂肿瘤的治疗,探讨了这种相对较新疾病的不同治疗选择和最新进展。提出了一种可能的最佳治疗方案。